The PE Ratio as of September 2024 (TTM) for Clearside Biomedical, Inc. (CLSD) is -2.60

According to Clearside Biomedical, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.60. This represents a change of -2.15% compared to the average of -2.66 of the last 4 quarters.

Clearside Biomedical, Inc. (CLSD) Historical PE Ratio (quarterly & annually)

How has CLSD PE Ratio performed in the past?

The mean historical PE Ratio of Clearside Biomedical, Inc. over the last ten years is 39.12. The current -2.60 PE Ratio has changed -764.63% with respect to the historical average. Over the past ten years (40 quarters), CLSD's PE Ratio was at its highest in in the December 2021 quarter at 2.19. The PE Ratio was at its lowest in in the September 2021 quarter at -18.25.

Clearside Biomedical, Inc. (CLSD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Clearside Biomedical, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clearside Biomedical, Inc. (CLSD) Average PE Ratio

How has CLSD PE Ratio performed in the past?

The current PE Ratio of Clearside Biomedical, Inc. (CLSD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Clearside Biomedical, Inc. (CLSD) PE Ratio vs. Peers

How is CLSD’s PE Ratio compared to its peers?

Clearside Biomedical, Inc.’s PE Ratio is less than POINT Biopharma Global Inc. (13.69), greater than ORIC Pharmaceuticals, Inc. (-6.41), less than Lyra Therapeutics, Inc. (-0.18), less than Inhibrx, Inc. (0.16), greater than ESSA Pharma Inc. (-11.72), less than Sensei Biotherapeutics, Inc. (-0.39), less than NextCure, Inc. (-0.59), less than Nuvation Bio Inc. (-1.48), less than Graphite Bio, Inc. (-0.13), greater than Merrimack Pharmaceuticals, Inc. (-8.92), greater than Gracell Biotechnologies Inc. (-12.28), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than Monte Rosa Therapeutics, Inc. (-3.20), greater than Design Therapeutics, Inc. (-6.26), greater than Erasca, Inc. (-3.85), less than Eyenovia, Inc. (-0.77), greater than Alpha Tau Medical Ltd. (-5.94), greater than Ocular Therapeutix, Inc. (-10.47), less than Tenaya Therapeutics, Inc. (-1.41), greater than Inozyme Pharma, Inc. (-4.20), less than Generation Bio Co. (-1.04), less than Kronos Bio, Inc. (-0.54), greater than C4 Therapeutics, Inc. (-3.99), greater than Edgewise Therapeutics, Inc. (-13.67),

Build a custom stock screener for Clearside Biomedical, Inc. (CLSD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clearside Biomedical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clearside Biomedical, Inc. (CLSD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clearside Biomedical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.